Naa10 in development and disease

Oncotarget. 2015 Oct 27;6(33):34041-2. doi: 10.18632/oncotarget.5867.

Authors

Line M Myklebust¹, Svein I Støve¹, Thomas Arnesen^{1

2}

Affiliations

¹ Department of Molecular Biology, University of Bergen, Bergen, Norway.
² Department of Surgery, Haukeland University Hospital, Bergen, Norway.

No abstract available

Keywords: N-terminal acetylation; Naa10; NatA.

Publication types

Editorial

MeSH terms

Acetylation
Arrhythmias, Cardiac / genetics
Cardiomyopathies / genetics
Craniofacial Abnormalities / genetics
Genetic Predisposition to Disease*
Humans
Infant
Infant, Newborn
Infant, Newborn, Diseases / genetics*
Infant, Newborn, Diseases / mortality
Muscle Hypotonia / genetics
N-Terminal Acetyltransferase A / deficiency
N-Terminal Acetyltransferase A / genetics*
N-Terminal Acetyltransferase E / deficiency
N-Terminal Acetyltransferase E / genetics*

Substances

N-Terminal Acetyltransferase A
NAA10 protein, human
N-Terminal Acetyltransferase E